What is the total value of Learningrx's common stock authorized, issued, and outstanding?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
| Stockholder's Equity | ||
|---|---|---|
| Common stock, no par value; 1,000 shares | ||
| authorized, issued, and outstanding | 50,000 | 50,000 |
| Retained earnings | 773,206 | 766,026 |
| Total Stockholders' Equity | 823,206 | 816,026 |
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the company's common stock, with no par value and 1,000 shares authorized, issued, and outstanding, is valued at $50,000 for both 2023 and 2022. This indicates that there were no changes in the common stock structure or value during these two fiscal years.
This information is relevant to potential Learningrx franchisees as it provides insight into the company's equity structure and financial stability. The fact that the common stock value remained constant over the two years could suggest stability in the company's ownership and capitalization.
However, it is important to note that this figure represents only the common stock portion of Learningrx's total stockholders' equity. The total stockholders' equity also includes retained earnings, which were $773,206 in 2023 and $766,026 in 2022. Therefore, prospective franchisees should consider the overall stockholders' equity and the company's liabilities to get a comprehensive view of Learningrx's financial health. Reviewing the complete balance sheets and related financial statements is crucial for assessing the company's financial position.